Cidara Thera (CDTX)

$0.97 0.05 (4.89%)

16:00 EDT CDTX Stock Quote Delayed 30 Minutes

Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now

By Josh Enomoto, InvestorPlace Contributor Aug 28, 2023

While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap 48.03M

PE Ratio -7.46

EPS -0.13

Volume (Avg. Vol.) 275,405

Day's Range $0.97 - $0.98

52-Week Range $0.46 - $2.10

Dividend & Yield N/A (N/A)

CDTX Stock Predictions, Articles, and Cidara Thera News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Mar 3, 2023

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

6 Cheap Stocks to Buy Under $7

By Maya Sasson, Writer, TipRanks Jan 15, 2020

No matter what, investors are always after returns. These six cheap stocks can make those returns a reality in 2020.

7 Stocks the Insiders Are Buying on Sale

By Mark Putrino, CMT Oct 1, 2019

Insiders sell stocks for many reasons, but the only reason they buy is that they believe they will profit. Check out these insider buying picks.

Biggest Movers in Manufacturing Stocks Now – VCEL AUPH ONVO CC

By Portfolio Grader Dec 13, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 12, 2016

This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 5, 2016

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – LPCN AXGN RETA CHRS

By Portfolio Grader Oct 7, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – SSNI INNL VBLT SPHS

By Portfolio Grader Jun 30, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX

By Portfolio Grader Jun 17, 2016

The following stocks were moving the Manufacturing sector today.

19 Biotechnology Stocks to Sell Now

By Portfolio Grader May 23, 2016

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Cidara Therapeutics shares fall as chief scientific officer sells ~18K stock (NASDAQ:CDTX)

From Seeking Alpha Sep 14, 2023

Cidara Therapeutics (CDTX) shares down 4.46% to $1.07 after the company disclosed on Sept

Cidara antifungal drug Rezzayo launched in US (NASDAQ:CDTX)

From Seeking Alpha Jul 31, 2023

Cidara Therapeutics (CDTX) said that commercial partner Melinta Therapeutics has launched its recently approved antifungal drug Rezzayo in the US. Read more here.

Cidara says J&J development deal for CD388 remains intact (NASDAQ:CDTX)

From Seeking Alpha Jul 20, 2023

Cidara Therapeutics (CDTX) said its agreement with J&J unit (JNJ) Janssen for its influenza drug CD388 remains intact despite Janssen move to cut infectious disease pipeline.

Cidara stock falls amid selloff in antifungal space (NASDAQ:CDTX)

From Seeking Alpha Mar 23, 2023

Despite strong gains early this week, antifungal drug developers sold off on Thursday even after FDA nod for Cidara's (CDTX) candidemia drug Rezzayo. Read more here.

Cidara stock dips despite FDA approval of antifungal drug Rezzayo

From Seeking Alpha Mar 23, 2023

The U.S. Food and Drug Administration (FDA) approved Cidara Therapeutics (CDTX) and Melinta Therapeutics' Rezzayo (rezafungin for injection) to treat candidemia and invasive candidiasis...

H.C. Wainwright Keeps Their Buy Rating on Cidara Therapeutics (CDTX)

From TipRanks Dec 2, 2022

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Cidara Therapeutics (CDTX – Research Report), with a price targ...